Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.5K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.5K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

18.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
18.8K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

65
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
65

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TOPS-CRISPR: Thermally-regulated and oligonucleotide-mediated one-pot CRISPR-Cas12a assay for ultra-sensitive and rapid on-site diagnostics.

Biosensors & bioelectronics·2026
Same author

Global breast cancer survival estimates in 2017-2021 to advance the WHO Global Breast Cancer Initiative.

Nature medicine·2026
Same author

Hijacking radiotherapy-induced chemokines with self-assembled molecular decoys for glioblastoma radio-immunotherapy.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Activation of BK channels ameliorates cardiac injury Via NFκB-NLRP3 signaling in angiotensin II-induced hypertension mouse model.

Frontiers in pharmacology·2026
Same author

CircCOL3A1 Drives Trophoblast Ferroptosis Through TIAL1-p53 Axis to Promote Preeclampsia Progression.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

BEACON: AIE-based point-of-care test for cross-species Brucella antibody detection.

Talanta·2026

Related Experiment Video

Updated: Mar 2, 2026

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

1.5K

Association between NLPR1, NLPR3, and P2X7R Gene Polymorphisms with Partial Seizures.

Haidong Wang1, Pengfei Xu2, Dehua Liao3

  • 1Department of Pharmacy, The First People's Hospital of Lianyungang, The Affiliated Hospital of Kangda College of Nanjing Medical University, Jiangsu, Lianyungang 222002, China.

Biomed Research International
|May 16, 2017
PubMed
Summary
This summary is machine-generated.

This study found a link between the NLRP1 rs878329 gene variant and partial seizures in males. This genetic factor may influence susceptibility to seizures in the Chinese Han population.

More Related Videos

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.7K
Pentylenetetrazole-Induced Kindling Mouse Model
07:06

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

35.2K

Related Experiment Videos

Last Updated: Mar 2, 2026

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

1.5K
Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.7K
Pentylenetetrazole-Induced Kindling Mouse Model
07:06

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

35.2K

Area of Science:

  • Neuroscience
  • Genetics
  • Immunology

Background:

  • Brain inflammation is crucial in seizure and epilepsy development.
  • Inflammasomes and P2X7 purinergic receptor (P2X7R) are key inflammatory mediators.
  • Understanding genetic links to seizures is vital for pathophysiology research.

Purpose of the Study:

  • To investigate the association between partial seizures and polymorphisms in NLPR1, NLRP3, and P2X7R genes.
  • To identify potential genetic risk factors for partial seizures.
  • To explore the role of specific gene variants in seizure susceptibility.

Main Methods:

  • Case-control study involving 163 partial seizure patients and 201 healthy controls.
  • Genotyping of NLPR1, NLRP3, and P2X7R gene polymorphisms using PCR-ligase detection reaction.
  • Statistical analysis of genotype and allele frequencies, including subgroup analysis by sex.

Main Results:

  • A significant association was found between the NLRP1 rs878329 (G>C) polymorphism and partial seizures (p=0.002).
  • This association was predominantly observed in males, with a higher frequency of the C allele in controls (p=0.004).
  • No significant associations were found for other tested polymorphisms (rs8079034, rs4612666, rs10754558, rs2027432, rs3751143, rs208294).

Conclusions:

  • The NLRP1 rs878329 (G>C) polymorphism may play a significant role in partial seizure susceptibility.
  • This genetic association appears to be sex-specific, particularly in males.
  • Further research is warranted to elucidate the precise mechanisms linking NLRP1 variants to epilepsy.